MedTrace Logo

UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies

NCT00578045 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2015-10-26

No results posted yet for this study

Summary

The researchers want to find out if subjects treated on this study will achieve long term bone marrow recovery (engraftment) and if their tumors will respond to this treatment.

Conditions

Interventions

PROCEDURE

Transfusion

Approximately 24 hours after the chemotherapy is completed you will receive the transfusion of the human cord blood

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Frits van Rhee, MD, PhD · University of Arkansas

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00578045 on ClinicalTrials.gov